Canada markets closed

Arcturus Therapeutics Holdings Inc. (ARCT)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Add to watchlist
20.75+0.84 (+4.22%)
At close: 04:00PM EDT
20.78 +0.03 (+0.14%)
After hours: 07:40PM EDT
Show:
Balance Sheet
Cash Flow
Annual

Income Statement

All numbers in thousands
Breakdown
ttm
2023-12-31
2022-12-31
2021-12-31
2020-12-31
Total Revenue
147,028
157,748
205,755
12,359
9,539
Operating Expenses
Research Development
199,939
192,133
147,751
173,760
57,846
Selling General and Administrative
53,051
52,871
46,071
41,451
23,217
Total Operating Expenses
236,152
235,953
193,578
215,211
81,063
Operating Income or Loss
-89,124
-78,205
12,177
-202,852
-71,524
Interest Expense
24
767
3,001
2,674
831
Total Other Income/Expenses Net
-491
33,724
-1,113
1,099
-263
Income Before Tax
-70,589
-27,890
10,644
-203,674
-72,148
Income Tax Expense
1,373
1,835
1,295
0
-
Income from Continuing Operations
-71,962
-29,725
9,349
-203,674
-72,148
Net Income
-71,962
-29,725
9,349
-203,674
-72,148
Net Income available to common shareholders
-71,962
-29,725
9,349
-203,674
-72,148
Basic EPS
3.76
-1.00
0.35
-7.74
-3.55
Diluted EPS
3.76
-1.00
0.35
-7.74
-3.55
Basic Average Shares
26,547
26,628
26,445
26,317
20,305
Diluted Average Shares
27,195
26,628
27,093
26,317
20,305